Copyright
©The Author(s) 2019.
World J Gastroenterol. Sep 21, 2019; 25(35): 5310-5322
Published online Sep 21, 2019. doi: 10.3748/wjg.v25.i35.5310
Published online Sep 21, 2019. doi: 10.3748/wjg.v25.i35.5310
Table 1 Correlation between lncRNA-ATB expression and clinicopathological parameters in patients with hepatocellular carcinoma
Clinical feature | n | LncRNA-ATB | P-value | |
High expression (n = 36) | Low expression (n = 36) | |||
Gender | 0.096 | |||
Male | 41 | 17 | 24 | |
Female | 31 | 19 | 12 | |
Age (yr) | 0.617 | |||
≤ 60 | 48 | 23 | 25 | |
> 60 | 24 | 13 | 11 | |
HBsAg | 0.306 | |||
Negative | 50 | 27 | 23 | |
Postive | 22 | 9 | 13 | |
AFP (ng/mL) | 0.216 | |||
≤ 400 | 25 | 15 | 10 | |
> 400 | 47 | 21 | 26 | |
Tumor size | 0.032a | |||
≤ 5cm | 41 | 16 | 25 | |
> 5cm | 31 | 20 | 11 | |
TNM stage | 0.017a | |||
I + II | 30 | 10 | 20 | |
III + IV | 42 | 26 | 16 | |
Differentiation | 0.465 | |||
Well/moderate | 45 | 21 | 24 | |
Poor | 27 | 15 | 12 |
- Citation: Wang CZ, Yan GX, Dong DS, Xin H, Liu ZY. LncRNA-ATB promotes autophagy by activating Yes-associated protein and inducing autophagy-related protein 5 expression in hepatocellular carcinoma. World J Gastroenterol 2019; 25(35): 5310-5322
- URL: https://www.wjgnet.com/1007-9327/full/v25/i35/5310.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i35.5310